Sanofi SA

Sanofi: Information concerning the total number of voting rights and shares - August 2025

12 Sep 2025 09:30:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration

10 Sep 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes

09 Sep 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

03 Sep 2025 22:01:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

03 Sep 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

29 Aug 2025 14:50:16 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - July 2025

18 Aug 2025 09:30:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

13 Aug 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

05 Aug 2025 22:00:00 By Nasdaq GlobeNewswire

Press release: Online availability of Sanofi’s half-year financial report for 2025

31 Jul 2025 09:20:00 By Nasdaq GlobeNewswire

Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range

30 Jul 2025 22:30:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

29 Jul 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

24 Jul 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

21 Jul 2025 22:30:00 By Nasdaq GlobeNewswire

Press Release: Sanofi completes acquisition of Blueprint Medicines

17 Jul 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi announces extension of Blueprint tender offer

16 Jul 2025 22:00:00 By Nasdaq GlobeNewswire

Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration

15 Jul 2025 22:00:00 By Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - June 2025

09 Jul 2025 09:29:17 By Nasdaq GlobeNewswire

Press release: Availability of the Q2 2025 Aide mémoire

29 Jun 2025 22:30:00 By Nasdaq GlobeNewswire

Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy

29 Jun 2025 22:00:00 By Nasdaq GlobeNewswire